November 27, 2023 — Qaelum NV, a leading provider of innovative healthcare solutions, and Philips, a global leader in health technology, have a strategic partnership to revolutionize radiation dose management in medical imaging. This collaboration marks a significant milestone in the quest to enhance patient safety and optimize healthcare workflows.
By offering a like-for-like replacement, Qaelum will ensure seamless continuity for existing Philips customers, providing them with ongoing support and access to Qaelum's expanding portfolio of software solutions. This partnership underscores the commitment of both parties to creating safer, more efficient, and higher-quality medical imaging environments.
Qaelum NV's expertise in dose monitoring and quality management, coupled with Philips' cutting-edge healthcare technology, creates a powerful synergy aimed at addressing the evolving challenges in radiation dose management. The collaboration will leverage Qaelum's Dose, a state-of-the-art radiation dose monitoring solution, and Philips' advanced imaging systems to deliver comprehensive and integrated solutions for healthcare providers worldwide.
Mr. Jurgen Jacobs, CEO and co-founder of Qaelum NV, commented, "This strategic partnership with Philips is a testament to our commitment to advancing healthcare solutions that prioritize patient safety and quality of care. By combining our expertise in radiation dose management with Philips' state-of-the-art imaging technology, we are poised to make a meaningful impact on global healthcare."
Mr. Vincent Roording, Procurement Manager OEM Solutions at Philips, added, "We are excited about the possibilities that this collaboration brings to the healthcare industry. The like-for-like replacement option of Qaelum, will also ensure continuity of service to our existing customers."
The partnership between Qaelum NV and Philips is set to redefine the landscape of radiation dose management in medical imaging, with a shared vision of advancing healthcare through innovation and collaboration.
For more information: www.qaelum.com
February 04, 2026 
